Five Alarm Bio seeking funding to develop drugs targeting the chronic diseases of ageing
Live Forever Club - 12-Feb-2025Promising preclinical results suggest a clear path towards drug development
Join the club for FREE to access the whole archive and other member benefits.
Company that develops drugs to slow down the ageing process
Visit website: http://www.fivealarmbio.com/
Details last updated 07-Nov-2020
Promising preclinical results suggest a clear path towards drug development
FAB1 compound reduces ageing markers in cells while FAB15 accelerates wound healing
No drug candidates yet, but great to see investors willing to support a broad attack on ageing
The company aims at treatments for a range of diseases associated with ageing and disabilities
Professor of Molecular Biogerontology at University of Birmingham Institute of Inflammation and Ageing, consultant, futurist, speaker